Varma Mutual Pension Insurance Company
Varma Mutual Pension Insurance Company is a prominent pension insurance provider based in Helsinki, Finland. Established in 1998 through the merger of Pension-Sampo and a significant segment of Pension-Varma, the company rebranded to its current name in December 2003. Varma offers a range of pension insurance services, including insurance coverage, vocational rehabilitation, and pension contribution estimates. Additionally, the company provides training and guidance focused on workplace well-being and social security for individuals working abroad. Its services extend to online platforms, client financing for pension foundations and funds, and advisory support for insured employees and entrepreneurs. Varma is committed to ensuring comprehensive pension solutions while promoting financial security for its clients.
Mediverkko is a healthcare and social service provider for private and municipal customers. It provides its customers with a full range of services from health care and dental clinics to elderly care as well as child welfare services for the public sector partners. Mediverkko is a Finland-based company that was founded in 2002. The company was acquired by Mehilainen on November 18, 2014.
Vivoxid Ltd. develops, manufactures, and markets biomaterial products for the medical device sector. The company offers MetAlive soft tissue attachment technology for implant surfaces; BonAlive bioactive glass and biodegradable polymer composite products in bone reconstruction; and FiberLive biodegradable fiberglass composites for load-bearing biodegradable implants. It has distributors in northern Europe, the United Kingdom, southern Europe, Italy, Greece, Turkey, the Middle East, and Saudi-Arabia. The company was founded in 2001 and is based in Turku, Finland.
Ipsat Therapies
Series C in 2005
Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.